Overview

Drug-drug Interaction Study of Biktarvy and Bemnifosbuvir/Ruzasvir

Status:
COMPLETED
Trial end date:
2024-05-30
Target enrollment:
Participant gender:
Summary
Drug-drug interaction study of Biktarvy and Bemnifosbuvir/Ruzasvir
Phase:
PHASE1
Details
Lead Sponsor:
Atea Pharmaceuticals, Inc.
Treatments:
bictegravir, emtricitabine, tenofovir alafenamide, drug combination